|
MSL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.185400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.010600E-01 |
| Normal-vs-Stage2 |
1.846820E-01 |
| Normal-vs-Stage3 |
3.260400E-02 |
| Normal-vs-Stage4 |
1.197650E-02 |
| Stage1-vs-Stage2 |
1.761800E-01 |
| Stage1-vs-Stage3 |
1.443550E-02 |
| Stage1-vs-Stage4 |
3.435100E-03 |
| Stage2-vs-Stage3 |
9.376400E-01 |
| Stage2-vs-Stage4 |
6.770800E-01 |
| Stage3-vs-Stage4 |
5.902200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.421000E-01 |
| Normal-vs-AfricanAmerican |
6.127900E-02 |
| Normal-vs-Asian |
3.175800E-01 |
| Caucasian-vs-AfricanAmerican |
3.175200E-01 |
| Caucasian-vs-Asian |
1.876960E-01 |
| AfricanAmerican-vs-Asian |
7.790000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.146000E-02 |
| Normal-vs-Female |
7.961400E-01 |
| Male-vs-Female |
4.162300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.514200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.672200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.374200E-02 |
| Normal-vs-Age(81-100Yrs) |
6.190800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.995600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.130800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.381400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.037700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.483800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.135860E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.368400E-02 |
| Normal-vs-Grade 2 |
7.806200E-01 |
| Normal-vs-Grade 3 |
1.284440E-02 |
| Normal-vs-Grade 4 |
8.644200E-03 |
| Grade 1-vs-Grade 2 |
1.068560E-01 |
| Grade 1-vs-Grade 3 |
7.414900E-04 |
| Grade 1-vs-Grade 4 |
1.600020E-03 |
| Grade 2-vs-Grade 3 |
4.845700E-04 |
| Grade 2-vs-Grade 4 |
2.042200E-03 |
| Grade 3-vs-Grade 4 |
3.573200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.062800E-01 |
| Normal-vs-ccB subtype |
2.760300E-02 |
| ccA subtype-vs-ccB subtype |
9.56189999999912E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.270000E-01 |
| Normal-vs-N1 |
3.851600E-01 |
| N0-vs-N1 |
7.788200E-01 |
|
|
